What question did this study set out to answer?

The study investigates how Ac2-26 affects nociception and joint damage in osteoarthritis models.

March 24, 2026Inflammation ResearchOpen Access

Pro-resolving Annexin A1-derived peptide Ac2-26 reduces nociception and mitigates joint damage in experimental osteoarthritis

View Full Paper

Ask AI

Bookmark

The study investigates how Ac2-26 affects nociception and joint damage in osteoarthritis models.
Utilized a mouse model of osteoarthritis
Administered the peptide Ac2-26
Assessed nociception and joint damage outcomes
Ac2-26 significantly reduced nociception
Markedly mitigated joint damage
Demonstrated protective effects on tissue damage

Implication

Experimental findings demonstrate that Ac2-26 reduces joint damage in osteoarthritis, suggesting potential therapeutic benefits.

Abstract

AnxA1 and Ac2-26 are promising molecules that regulate key processes in OA, effectively mitigating tissue damage and dysfunction in a model of OA in mice.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Bosi et al. (2026) studied this question.

synapsesocial.com/papers/69c2299aaeb5a845df0d440a https://doi.org/10.1007/s00011-026-02191-z

View Full Paper

Ask AI

Bookmark

Implication

Experimental findings demonstrate that Ac2-26 reduces joint damage in osteoarthritis, suggesting potential therapeutic benefits.

Abstract

AnxA1 and Ac2-26 are promising molecules that regulate key processes in OA, effectively mitigating tissue damage and dysfunction in a model of OA in mice.

Pro-resolving Annexin A1-derived peptide Ac2-26 reduces nociception and mitigates joint damage in experimental osteoarthritis

Key Points

Implication

Abstract

Discussion

Cite This Study

Pro-resolving Annexin A1-derived peptide Ac2-26 reduces nociception and mitigates joint damage in experimental osteoarthritis

Key Points

Implication

Abstract

Discussion

Cite This Study

Keep reading

Keep reading